The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2014

Filed:

Nov. 14, 2008
Applicants:

Frank Himmelsbach, Mittelbiberach, DE;

Matthias Eckhardt, Biberach, DE;

Bradford S. Hamilton, Biberach, DE;

Armin Heckel, Biberach, DE;

Joerg Kley, Mittelbiberach, DE;

Thorsten Lehmann-lintz, Ochsenhausen, DE;

Herbert Nar, Ochsenhausen, DE;

Stefan Peters, Biberach, DE;

Annette Schuler-metz, Ulm, DE;

Matthias Zentgraf, Biberach, DE;

Inventors:

Frank Himmelsbach, Mittelbiberach, DE;

Matthias Eckhardt, Biberach, DE;

Bradford S. Hamilton, Biberach, DE;

Armin Heckel, Biberach, DE;

Joerg Kley, Mittelbiberach, DE;

Thorsten Lehmann-Lintz, Ochsenhausen, DE;

Herbert Nar, Ochsenhausen, DE;

Stefan Peters, Biberach, DE;

Annette Schuler-Metz, Ulm, DE;

Matthias Zentgraf, Biberach, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 221/26 (2006.01); C07D 417/06 (2006.01); C07D 401/06 (2006.01); C07D 471/08 (2006.01); C07D 498/08 (2006.01); C07D 413/14 (2006.01); C07D 413/06 (2006.01); C07D 405/06 (2006.01); C07D 401/14 (2006.01); C07D 451/06 (2006.01); C07D 403/06 (2006.01);
U.S. Cl.
CPC ...
C07D 221/26 (2013.01); C07D 417/06 (2013.01); C07D 401/06 (2013.01); C07D 471/08 (2013.01); C07D 498/08 (2013.01); C07D 413/14 (2013.01); C07D 413/06 (2013.01); C07D 405/06 (2013.01); C07D 401/14 (2013.01); C07D 451/06 (2013.01); C07D 403/06 (2013.01);
Abstract

The present invention relates to compounds defined by formula I wherein the groups Rto R, X, m, n and o are defined as in claim, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.


Find Patent Forward Citations

Loading…